HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients.

Abstract
Dementia with Lewy bodies (DLB) is common. Symptomatic treatment can be difficult. We reviewed nine consecutive patients with DLB (mean age 77.5 [range 67 to 84] years; seven men and two women; mean duration of disease 3.7 [range 1.5 to 8.0] years) who had been treated with donepezil. Each initially received 2.5 to 5 mg per day of donepezil, and was stabilized on 5 mg per day. Donepezil was increased to 10 mg per day in five patients. The mean observation period was 12 (range 8 to 24) weeks. Target symptoms included cognition, hallucinations, parkinsonism, and functional abilities. By both cognitive testing and family reports, cognition improved in seven of nine patients, remained the same in one of nine, and fluctuated in one of nine (mean Mini-Mental State Examination change 4.4 +/- 6.3 points). Function was improved or maintained in six of nine patients and fluctuated in two of nine. Hallucinations initially worsened, then fluctuated in one patient, but improvement in frequency, duration, and content was reported in eight of nine cases. In three of nine patients, treatment with donepezil resulted in worsening of parkinsonism, which in each case responded to levodopa/carbidopa. Treatment of DLB patients with donepezil for 12 weeks most commonly improved hallucinations, and sometimes improved cognition and overall function. Treatment with donepezil was sometimes associated with worse parkinsonism.
AuthorsC Shea, C MacKnight, K Rockwood
JournalInternational psychogeriatrics (Int Psychogeriatr) Vol. 10 Issue 3 Pg. 229-38 (Sep 1998) ISSN: 1041-6102 [Print] England
PMID9785144 (Publication Type: Case Reports, Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Indans
  • Nootropic Agents
  • Piperidines
  • Donepezil
Topics
  • Activities of Daily Living
  • Aged
  • Aged, 80 and over
  • Dementia (drug therapy, pathology)
  • Donepezil
  • Female
  • Geriatric Assessment
  • Humans
  • Indans (therapeutic use)
  • Lewy Bodies (pathology)
  • Male
  • Mental Status Schedule
  • Nootropic Agents (therapeutic use)
  • Parkinson Disease, Secondary (drug therapy, pathology)
  • Piperidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: